Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival

GB. Stefano, R. Ptacek, H. Ptackova, A. Martin, RM. Kream

. 2021 ; 27 (-) : e930886. [pub] 20210125

Language English Country United States

Document type Editorial

Alterations in brain functioning, especially in regions associated with cognition, can result from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and are predicted to result in various psychiatric diseases. Recent studies have shown that SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) can directly or indirectly affect the central nervous system (CNS). Therefore, diseases associated with sequelae of COVID-19, or 'long COVID', also include serious long-term mental and cognitive changes, including the condition recently termed 'brain fog'. Hypoxia in the microenvironment of select brain areas may benefit the reproductive capacity of the virus. It is possible that in areas of cerebral hypoxia, neuronal cell energy metabolism may become compromised after integration of the viral genome, resulting in mitochondrial dysfunction. Because of their need for constant high metabolism, cerebral tissues require an immediate and constant supply of oxygen. In hypoxic conditions, neurons with the highest oxygen demand become dysfunctional. The resulting cognitive impairment benefits viral spread, as infected individuals exhibit behaviors that reduce protection against infection. The effects of compromised mitochondrial function may also be an evolutionary advantage for SARS-CoV-2 in terms of host interaction. A high viral load in patients with COVID-19 that involves the CNS results in the compromise of neurons with high-level energy metabolism. Therefore, we propose that selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce 'brain fog' and results in behavioral changes that favor viral propagation. Cognitive changes associated with COVID-19 will have increasing significance for patient diagnosis, prognosis, and long-term care.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011581
003      
CZ-PrNML
005      
20210507103503.0
007      
ta
008      
210420s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.12659/MSM.930886 $2 doi
035    __
$a (PubMed)33487628
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Stefano, George B $u Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
245    10
$a Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival / $c GB. Stefano, R. Ptacek, H. Ptackova, A. Martin, RM. Kream
520    9_
$a Alterations in brain functioning, especially in regions associated with cognition, can result from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and are predicted to result in various psychiatric diseases. Recent studies have shown that SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) can directly or indirectly affect the central nervous system (CNS). Therefore, diseases associated with sequelae of COVID-19, or 'long COVID', also include serious long-term mental and cognitive changes, including the condition recently termed 'brain fog'. Hypoxia in the microenvironment of select brain areas may benefit the reproductive capacity of the virus. It is possible that in areas of cerebral hypoxia, neuronal cell energy metabolism may become compromised after integration of the viral genome, resulting in mitochondrial dysfunction. Because of their need for constant high metabolism, cerebral tissues require an immediate and constant supply of oxygen. In hypoxic conditions, neurons with the highest oxygen demand become dysfunctional. The resulting cognitive impairment benefits viral spread, as infected individuals exhibit behaviors that reduce protection against infection. The effects of compromised mitochondrial function may also be an evolutionary advantage for SARS-CoV-2 in terms of host interaction. A high viral load in patients with COVID-19 that involves the CNS results in the compromise of neurons with high-level energy metabolism. Therefore, we propose that selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce 'brain fog' and results in behavioral changes that favor viral propagation. Cognitive changes associated with COVID-19 will have increasing significance for patient diagnosis, prognosis, and long-term care.
650    _2
$a COVID-19 $x komplikace $x metabolismus $x patofyziologie $x psychologie $x přenos $7 D000086382
650    _2
$a kognitivní dysfunkce $x metabolismus $x patofyziologie $x psychologie $7 D060825
650    _2
$a energetický metabolismus $7 D004734
650    12
$a zdravé chování $7 D015438
650    _2
$a lidé $7 D006801
650    _2
$a mozková hypoxie $x metabolismus $x patofyziologie $x psychologie $7 D002534
650    _2
$a mikrobiální viabilita $7 D050296
650    _2
$a mitochondrie $x metabolismus $7 D008928
650    _2
$a neurony $x metabolismus $7 D009474
650    _2
$a SARS-CoV-2 $x fyziologie $7 D000086402
650    _2
$a virová nálož $7 D019562
650    _2
$a replikace viru $7 D014779
655    _2
$a úvodníky $7 D016421
700    1_
$a Ptacek, Radek $u Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Ptackova, Hana $u Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Martin, Anders $u Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Kream, Richard M $u Center for Cognitive and Molecular Neuroscience, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
773    0_
$w MED00003251 $t Medical science monitor : international medical journal of experimental and clinical research $x 1643-3750 $g Roč. 27, č. - (2021), s. e930886
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33487628 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103502 $b ABA008
999    __
$a ok $b bmc $g 1650068 $s 1131960
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 27 $c - $d e930886 $e 20210125 $i 1643-3750 $m Medical Science Monitor $n Med Sci Monit $x MED00003251
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...